Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Haug

Showing results (41-50 of 151) with videos related to

Pageof 16
Sort By:
American Journal of Epidemiology|April 3, 2025
Misleading and avoidably: design-induced biases in observational studies evaluating cancer screening-the example of site-specific effectiveness of screening colonoscopyMalte Braitmaier, Sarina Schwarz, Vanessa Didelez, et al.
Gastrointestinal Endoscopy|February 21, 2012
Subsite-specific colorectal cancer risk in the colorectal endoscopy eraChristian Stock, Dianne Pulte, Ulrike Haug, et al.
British Journal of Clinical Pharmacology|September 28, 2020
How often are antidepressants prescribed off-label among older adults in Germany? A claims data analysisWiebke Schäfer, Tammo Reinders, Oliver Riedel, et al.
Plos One|March 4, 2014
Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from GermanyUlrike Haug, Susanne Engel, Frank Verheyen, et al.
Drugs - Real World Outcomes|November 26, 2025
Use of Carbimazole, Methimazole and Propylthiouracil in Women of Childbearing Age and Exposed Pregnancies in Germany: A Population-Based StudyTania Schink, Maxim Frizler, Bianca Kollhorst, et al.
BMC Medical Research Methodology|July 10, 2019
Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry dataKatja Anita Oppelt, Sabine Luttmann, Klaus Kraywinkel, et al.
Future Oncology (London, England)|March 31, 2021
Potential of German claims data to characterize utilization of new cancer drugs: the example of crizotinibSarina Schwarz, Katja A Oppelt, Miriam Heinig, et al.
British Journal of Cancer|March 22, 2018
First-degree relatives of cancer patients: a target group for primary prevention? A cross-sectional studyUlrike Haug, Oliver Riedel, Constanze Cholmakow-Bodechtel, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 25, 2013
Consideration of family history of cancer in medical routine: a survey in the primary care setting in GermanyJonas Fiederling, Cornelia M Ulrich, Kari Hemminki, et al.
Clinical Epidemiology|July 24, 2023
Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in GermanyAnnemarie Voss, Bianca Kollhorst, Katharina Platzbecker, et al.
Pageof 16

Showing results (41-50 of 151) with videos related to

Sort By:
Pageof 16
American Journal of Epidemiology|April 3, 2025
Misleading and avoidably: design-induced biases in observational studies evaluating cancer screening-the example of site-specific effectiveness of screening colonoscopyMalte Braitmaier, Sarina Schwarz, Vanessa Didelez, et al.
Gastrointestinal Endoscopy|February 21, 2012
Subsite-specific colorectal cancer risk in the colorectal endoscopy eraChristian Stock, Dianne Pulte, Ulrike Haug, et al.
British Journal of Clinical Pharmacology|September 28, 2020
How often are antidepressants prescribed off-label among older adults in Germany? A claims data analysisWiebke Schäfer, Tammo Reinders, Oliver Riedel, et al.
Plos One|March 4, 2014
Estimating colorectal cancer treatment costs: a pragmatic approach exemplified by health insurance data from GermanyUlrike Haug, Susanne Engel, Frank Verheyen, et al.
Drugs - Real World Outcomes|November 26, 2025
Use of Carbimazole, Methimazole and Propylthiouracil in Women of Childbearing Age and Exposed Pregnancies in Germany: A Population-Based StudyTania Schink, Maxim Frizler, Bianca Kollhorst, et al.
BMC Medical Research Methodology|July 10, 2019
Incidence of advanced colorectal cancer in Germany: comparing claims data and cancer registry dataKatja Anita Oppelt, Sabine Luttmann, Klaus Kraywinkel, et al.
Future Oncology (London, England)|March 31, 2021
Potential of German claims data to characterize utilization of new cancer drugs: the example of crizotinibSarina Schwarz, Katja A Oppelt, Miriam Heinig, et al.
British Journal of Cancer|March 22, 2018
First-degree relatives of cancer patients: a target group for primary prevention? A cross-sectional studyUlrike Haug, Oliver Riedel, Constanze Cholmakow-Bodechtel, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|July 25, 2013
Consideration of family history of cancer in medical routine: a survey in the primary care setting in GermanyJonas Fiederling, Cornelia M Ulrich, Kari Hemminki, et al.
Clinical Epidemiology|July 24, 2023
Risk Profiles of New Users of Oral Anticoagulants Between 2011 and 2019 in GermanyAnnemarie Voss, Bianca Kollhorst, Katharina Platzbecker, et al.
Pageof 16